Showing results (141-150 of 287) with videos related to

Sort By:
Pageof 29
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 4, 2000
PET-Determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brainL Farde, B Andrée, N Ginovart, et al.
Psychopharmacology|January 1, 1993
5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidoneS Nyberg, L Farde, L Eriksson, et al.
Journal of Medical Systems|August 1, 1987
Use of graphical techniques for error evaluationG Q Maguire, J Jaeger, L Farde, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|September 18, 1998
Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride bindingH Ito, J Hietala, G Blomqvist, et al.
The American Journal of Psychiatry|June 9, 1999
Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patientsS Nyberg, B Eriksson, G Oxenstierna, et al.
Psychopharmacology|March 1, 1994
Influence of rate of administration of raclopride on akathisia and prolactin responseG Movin-Osswald, P Karlsson, M Hammarlund-Udenaes, et al.
Psychopharmacology|February 1, 1994
An open clinical and biochemical study of ritanserin in acute patients with schizophreniaF A Wiesel, A L Nordström, L Farde, et al.
Psychopharmacology|June 1, 1997
Central 5-HT2A and D2 dopamine receptor occupancy after sublingual administration of ORG 5222 in healthy menB Andrée, C Halldin, M Vrijmoed-de Vries, et al.
Pageof 29